Revance Therapeutics, Inc. (NASDAQ:RVNC) Short Interest Down 14.6% in December
Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) saw a significant decline in short interest in the month of December. As of December 31st, there was short interest totalling 8,340,000 shares, a decline of 14.6% from the December 15th total of 9,770,000 shares. Based on an average trading volume of 2,720,000 shares, the days-to-cover ratio […]
More Stories
US Foreclosure Filings Jump 5 Percent in February
By Naveen Athrappully The number of foreclosure filings in the United States rose by 5 percent in February over the...
Sugary Drinks Linked to an Increase in Oral Cancer Risk Among Women: New Research
By George Citroner Women who indulge in just one sugar-sweetened beverage a day are nearly five times more likely to...
Canada’s Ambassador, Ontario Rep Say They Have Clearer Idea of What Trump Is After Following DC Meeting
By Isaac Teo Canadian representatives say they now have a clearer understanding of what U.S. President Donald Trump is pursuing...
More Than 250 Tren de Aragua Gang Members Deported to El Salvador Prison: Rubio
By Jacob Burg Secretary of State Marco Rubio said on March 16 that the Trump administration had sent more than...
ICE Arrests 214 Criminal Illegal Immigrants in Virginia
By Naveen Athrappully An enforcement operation in northern Virginia has led to the arrests of 214 criminal illegal immigrants, including...
The AES Co. (NYSE:AES) Shares Sold by PNC Financial Services Group Inc.
PNC Financial Services Group Inc. reduced its position in shares of The AES Co. (NYSE:AES – Free Report) by 19.9%...